You are here

AstraZeneca

With an assist from AstraZeneca, the salvage crew at Sierra bets another $216M they can resurrect an old Gilead JAK drug

Endpoints

Fri, 08/6/21 - 11:07 am

Gilead Sciences

Sierra Oncology

AstraZeneca's launch plan for first-in-class lupus med Saphnelo centers on patient-designed support program

Fierce Pharma

Tue, 08/3/21 - 11:13 am

patient advocacy groups

AstraZeneca nabs FDA nod to challenge GSK's Benlysta with first-in-class lupus drug Saphnelo

Fierce Pharma

Mon, 08/2/21 - 11:08 am

systemic lupus erythematosus

AstraZeneca still eyes US vaccine filing despite another delay

BioPharma Dive

Thu, 07/29/21 - 11:14 am

AstraZeneca and Amgen quietly admit tezepelumab defeat as the Dupixent challenger heads to FDA

Endpoints

Thu, 07/29/21 - 11:10 am

AZ’s COVID-19 jab sales top $1.2bn, but come at a loss

Pharmaforum

Thu, 07/29/21 - 11:01 am

AstraZeneca and mRNA COVID-19 vaccines ‘show similar safety profiles’

Biopharma Reporter

Wed, 07/28/21 - 11:24 pm

AstraZeneca Shot Brings No Increased Blood-Clot Risk After Two Doses

Bloomberg

Wed, 07/28/21 - 10:26 am

An AstraZeneca spinout scores a buyout option from Arena

BioPharma Dive

Wed, 07/28/21 - 10:06 am

Aristea Therapeutics

Arena Pharmaceuticals

AstraZeneca teams up with Regeneron for obesity-busting drug pact focused on genetics

Fierce Biotech

Tue, 07/27/21 - 10:29 am

AstraZeneca's newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says

Fierce Pharma

Sun, 07/25/21 - 11:44 am

myasthenia gravis

Wins for AstraZeneca: Diabetes Drug Approved for Teens, Covid Vaccine Effective against Delta Variant

BioSpace

Fri, 07/23/21 - 12:49 pm

type 2 diabetes

Study finds vaccines cut severe variant COVID disease after one shot

Pharmaforum

Fri, 07/23/21 - 11:13 am

real world evidence

Delta COVID-19 variant

Two doses of Pfizer, AstraZeneca shots effective against Delta variant: study

Reuters

Wed, 07/21/21 - 09:09 pm

Delta COVID-19 variant

AstraZeneca heralds new chapter as Alexion acquisition completed

Biopharma Reporter

Wed, 07/21/21 - 08:46 pm

Alexion's new blockbuster Ultomiris keeps gaining steam as $39B AstraZeneca deal looms

Fierce Pharma

Wed, 07/21/21 - 12:01 am

AstraZeneca earns another approval in jam-packed Chinese PD-(L)1 market, this time in late-stage lung cancer

Endpoints

Mon, 07/19/21 - 11:05 am

Alexion touts new PhIII data of Soliris successor as planned AstraZeneca takeover looms

Endpoints

Fri, 07/16/21 - 10:40 am

clinical trials

myasthenia gravis

Novartis may have the most new drug approvals, but Roche, Lilly and AbbVie's launches win on value: report

Fierce Pharma

Thu, 07/15/21 - 12:39 pm

AZ, J&J tweaking COVID shots to reduce clotting risks; report

Pharmaforum

Wed, 07/14/21 - 10:38 am

Pages